Catalyst Wire Dossier Catalyst Wire Dossier

Prismocitrate 18

· Vantive Health LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Prismocitrate 18, covering 2021-01-05 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT [Phase 3]

See pricing